Inhibition of autophosphorylation of epidermal growth factor receptor by small peptides in vitro

British Journal of Pharmacology

Volumn 147, Issue 4, 2006, Pages 402-411

  Abe, Mineo ^a   Kuroda, Yoshihiro ^a   Hirose, Munetaka ^b   Watanabe, Yoshihiko ^a   Nakano, Minoru ^a   Handa, Tetsurou ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

AG1478; DYQQD; EGF; EGFR; ENAEYLR; Epidermal growth factor; Lignocaine; Phosphorylation; Tyrosine kinase; VPEYINQ

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; ACETYLASPARTYLISOLEUCYLTYROSYLGLUTAMYLTHREONINAMIDE; ACETYLASPARTYLTYROSYLGLUTAMINYLGLUTAMINYLASPARTYLAMIDE; ACETYLGLUTAMYLASPARAGINYLALANYLGLUTAMYLTYROSYLLEUCYLARGININAMIDE; ACETYLLEUCYLPROLYLPHENYLALANYLPHENYLALANYLASPARTYLAMIDE; ACETYLLYSYLISOLEUCYLPHENYLALANYLMETHIONYLLYSINAMIDE; ACETYLLYSYLISOLEUCYLTYROSYLGLUTAMYLLYSINAMIDE; ACETYLVALYLPROLYLGLUTAMYLTYROSYLISOLEUCYLASPARAGINYLGLUTAMINAMIDE; EPIDERMAL GROWTH FACTOR RECEPTOR; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; Y 1068; Y 1148; Y 1173; Y 992;

AMINO ACID SEQUENCE; ARTICLE; AUTOPHOSPHORYLATION; DRUG DESIGN; DRUG EFFECT; DRUG POTENCY; IC 50; IN VITRO STUDY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PURIFICATION; SEPARATION TECHNIQUE; WESTERN BLOTTING;

ADENOSINE TRIPHOSPHATE; AMINO ACID SEQUENCE; BINDING SITES; BLOTTING, WESTERN; DRUG INTERACTIONS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; PHOSPHORYLATION; PROTEIN-TYROSINE-PHOSPHATASE; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, INSULIN; TYRPHOSTINS;

EID: 33644513755     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706634     Document Type: Article

References (35)

1. BASELGA, J. (2004). The science of EGFR inhibition: A roadmap to improved outcomes? Signal, 5, 4-8.
2. BLAKESLEY, V.A., SCRIMGEOUR, A., ESPOSITO, D. & ROITH, D.L. (1996). Signaling via the insulin-like growth factor-I receptor: Does it differ from insulin receptor signaling? Cytokine Growth Factor Rev., 7, 153-159.
3. CHANTRY, A. (1995). The kinase domain and membrane localization determine intracellular interactions between epidermal growth factor receptors. J. Biol. Chem., 270, 3068-3073.
4. DOWNWARD, J., PARKER, P. & WATERFIELD, M.D. (1984). Autophosphorylation sites on the epidermal growth factor receptor. Nature, 311, 483-485.
5. EAHOLTZ, G., COLVIN, A., LEONARD, D., TAYLOR, C. & CATTERALL, W.A. (1999). Block of brain sodium channels by peptide mimetics of the isoleucine, phenylalanine, and methionine (IFM) motif from the inactivation gate. J. Gen. Physiol., 113, 279-293.
6. EAHOLTZ, G., SCHEUER, T. & CATTERALL, W.A. (1994). Restoration of inactivation and block of open sodium channels by an inactivation gate peptide. Neuron., 12, 1041-1048.
7. HIROSE, M., KURODA, Y., SAWA, S., NAKAGAWA, T., HIRATA, M., SAKAGUCHI, M. & TANAKA, Y. (2004). Suppression of insulin signaling by a synthetic peptide KIFMK suggests the cytoplasmic linker between DIII-S6 and DIV-S1 as a local anaesthetic binding site on the sodium channel. Br. J. Pharmacol., 142, 222-228.
8. HIROSE, M., MARTYN, J.A.J., KURODA, Y., MARUNAKA, Y. & TANAKA, Y. (2002). Mechanism of suppression of insulin signalling with lignocaine. Br. J. Pharmacol., 136, 76-80.
9. HSUAN, J.J., TOTTY, N. & WATERFIELD, M.D. (1989). Identification of a novel autophosphorylation site (P4) on the epidermal growth factor receptor. Biochem. J., 262, 659-663.
10. HUBBARD, S.R. (1997). Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog. EMBO J., 16, 5572-5581.
11. HUBBARD, S.R., MOHAMMADI, M. & SCHLESSINGER, J. (1998). Autoregulatory mechanisms in protein-tyrosine kinases. J. Biol. Chem., 273, 11987-11990.
12. HUBBARD, S.R., WEI, L., ELLIS, L. & HENDRICKSON, W.A. (1994). Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature, 372, 746-754.
13. HUNTER, T. (1998). The phosphorylation of proteins on tyrosine: its role in cell growth and disease. Philos. Trans. R. Soc. London B Biol. Sci., 353, 583-605.
14. JORISSEN, R.N., WALKER, F., POULIOT, N., GARRETT, T.P.J., WARD, C.W. & BURGESS, A.W. (2003). Epidermal growth factor receptor: mechanisms of activation and signaling. Exp. Cell Res., 284, 31-53.
15. KASUGA, M., ZICK, Y., BLITH, D.L., KARLSSON, F.A., HARING, H.U. & KAHN, C.R. (1982). Insulin stimulation of phosphorylation of the β subunit of the insulin receptor. J. Biol. Chem., 257, 9891-9894.
16. KELEMEN, B.R., HSIAO, K. & GOUELI, S.A. (2002). Selective in vitro inhibition of mitogen-activated protein kinase activation using cell-permeable peptides. J. Biol. Chem., 277, 8741-8748.
17. KEMP, B.E. & PEARSON, R.B. (1991). Intrasteric regulation of protein kinases and phosphatases. Biochim. Biophys. Acta., 1094, 67-76.
18. KRAUS, M.H., ISSING, W., MIKI, T., POPESCU, N.C. & AARONSON, S.A. (1989). Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors. Proc. Natl. Acad. Sci. U.S.A., 86, 9193-9197.
19. 1H-NMR and circular dichroism spectroscopic studies on changes in secondary structures of the sodium channel inactivation gate peptides as caused by the pentapeptide KIFMK. Biophys. J., 77, 1363-1373.
20. LEMMON, M.A., BU, Z., LADBURY, J.E., ZHOU, M., PINCHASI, D., LAX, I., ENGELMAN, D.M. & SCHLESSINGER, J. (1997). Two EGF molecules contribute additively to stabilization of the EGFR dimer. EMBO J., 16, 281-294.
21. LEVITZKI, A. (2003). Protein kinase inhibitors as a therapeutic modality. Acc. Chem. Res., 36, 462-469.
22. LEVITZKI, A. & GAZIT, A (1995). Tyrosine kinase inhibition: an approach to drug development. Science, 267, 1782-1787.
23. LEVKOWITZ, G., WATERMAN, H., ETTENBERG, S.A., KATZ, M., TSYGANKOV, A.Y., ALROY, I., LAVI, S., IWAI, K., REISS, Y., CIECHANOVER, A., LIPKOWITZ, S. & YARDEN, Y. (1999). Uniquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1. Mol. Cell. 4, 1029-1040.
24. MARGOLIS, B.L., LAX, I., KRIS, R., DOMBALAGIAN, M., HONEGGER, A.M., HOWK, R., GIVOL, D., ULLRICH, A. & SCHLESSINGER, J. (1989). All autophosphorylation sites of epidermal growth factor (EGF) receptor and HER2/neu are located in their carboxyl-terminal tails. J. Biol. Chem., 264, 10667-10671.
25. MARMOR, M.D. & YARDEN, Y. (2003). EGF receptor family. In: Handbook of Cell Signaling, eds. Bradshaw, R.A. & Dennis, E.A. Vol. 1, pp. 405-408. New York: Academic Press.
26. OSHEROV, N., GAZIT, A., GILON, C. & LEVITZKI, A. (1993). Selective inhibition of the epidermal growth factor and HER2/Neu receptors by tyrphostins. J. Biol. Chem., 268, 11134-11142.
27. erbB4, a fourth member of the epidermal growth factor receptor family. Proc. Natl. Acad. Sci. U.S.A., 90, 1746-1750.
28. RANSON, M. (2004). Epidermal growth factor receptor tyrosine kinase inhibitors. Br. J. Cancer, 90, 2250-2255.
29. SCHLESSINGER, J. (2000). Cell signaling by receptor tyrosine kinases. Cell, 103, 211-225.
30. v-src kinases. J. Biol. Chem., 264, 7831-7836.
31. TICE, D.A., BISCARDI, J.S., NICKLES, A.L. & PARSONS, S.J. (1999). Mechanism of biological synergy between cellular Src and epidermal growth factor receptor. Proc. Natl. Acad. Sci. U.S.A., 96, 1415-1420.
32. TRAUT, T.W. (1994). Physiological concentrations of purines and pyrimidines. Mol. Cell. Biochem., 140, 1-22.
33. VIVES, E., BRODIN, P. & LEBLEU, B. (1997). A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem., 272, 16010-16017.
34. WALTON, G.M., CHEN, W.S., ROSENFELD, M.G. & GILL, G.N. (1990). Analysis of deletions of the carboxyl terminus of the epidermal growth factor receptor reveals self-phosphorylation at tyrosine 992 and enhances in vivo tyrosine phosphorylation of cell substrates. J. Biol. Chem., 265, 1750-1754.
35. YAMAMOTO, T., IKAWA, S., AKIYAMA, T., SEMBA, K., NOMURA, N., MIYAJIMA, N., SAITO, T. & TOYOSHIMA, K. (1986). Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor. Nature, 319, 230-234.